|
RSC1A1 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 2.10730000116399E-08 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
4.26419999310923E-09 |
| Normal-vs-Stage2 |
4.791600E-04 |
| Normal-vs-Stage3 |
2.32620000040207E-07 |
| Normal-vs-Stage4 |
9.58979999965415E-07 |
| Stage1-vs-Stage2 |
5.115800E-01 |
| Stage1-vs-Stage3 |
8.810800E-01 |
| Stage1-vs-Stage4 |
2.901800E-01 |
| Stage2-vs-Stage3 |
6.549400E-01 |
| Stage2-vs-Stage4 |
1.219430E-01 |
| Stage3-vs-Stage4 |
1.568370E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
4.89840001893782E-09 |
| Normal-vs-AfricanAmerican |
1.4082000010518E-08 |
| Normal-vs-Asian |
4.084300E-03 |
| Caucasian-vs-AfricanAmerican |
6.058800E-01 |
| Caucasian-vs-Asian |
9.612400E-01 |
| AfricanAmerican-vs-Asian |
8.120200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.20510276704999E-11 |
| Normal-vs-Female |
1.816490E-02 |
| Male-vs-Female |
5.079700E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
1.6967000000534E-06 |
| Normal-vs-Extreme_Weight |
1.62458935193399E-12 |
| Normal-vs-Obese |
1.6373000000236E-06 |
| Normal-vs-Extreme_Obese |
1.578430E-04 |
| Normal_Weight-vs-Extreme_Weight |
1.390240E-01 |
| Normal_Weight-vs-Obese |
6.663600E-01 |
| Normal_Weight-vs-Extreme_Obese |
8.179400E-01 |
| Extreme_Weight-vs-Obese |
1.287960E-02 |
| Extreme_Weight-vs-Extreme_Obese |
3.797400E-01 |
| Obese-vs-Extreme_Obese |
5.919400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.38669999998997E-05 |
| Normal-vs-Age(41-60Yrs) |
6.27630003524615E-09 |
| Normal-vs-Age(61-80Yrs) |
4.19840000542848E-08 |
| Normal-vs-Age(81-100Yrs) |
1.15609999995492E-06 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
8.920400E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
9.773200E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
4.295200E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
7.455200E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.889170E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
2.814400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
1.63802305053196E-12 |
| Normal-VS-Type2 PRCC |
1.93810000004291E-06 |
| Normal-VS-KIRP CIMP |
2.198600E-03 |
| Normal-VS-Unclassified PRCC |
6.12500000000127E-05 |
| Type1 PRCC-VS-Type2 PRCC |
5.161600E-02 |
| Type1 PRCC-VS-KIRP CIMP |
1.880970E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
4.489600E-02 |
| Type2 PRCC-VS-KIRP CIMP |
9.041600E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
9.261400E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
9.451800E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
3.260000047689E-09 |
| Normal-vs-N1 |
2.30930000011398E-07 |
| Normal-vs-N2 |
1.059110E-03 |
| N0-vs-N1 |
7.484800E-01 |
| N0-vs-N2 |
5.443200E-01 |
| N1-vs-N2 |
3.723400E-01 |
|
|
